We noted you are experiencing viewing problems
- 
        
        Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
- 
        
        Check the following talk links to see which ones work correctly:
 Auto Mode
 HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems.
- 
        
        No luck yet? More tips for troubleshooting viewing issues
- 
        
        Contact HST Support access@hstalks.com
- 
        Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
- 
        For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
                    
                    This is a limited length demo talk; you may
                    
                      login or
                    
                    review methods of
                    obtaining more access.
                  
                
                
              - Models of Investigation
- 
                                
                                1. Antifungal innate immunity in C. elegans- Dr. Jonathan Ewbank
 
- 
                                
                                2. Macrophages and systems biology- Prof. David Hume
 
- Cell Types and Recruitment
- 
                                
                                3. Eosinophils- Prof. Tim Williams
 
- Modulation of Effector Responses
- 
                                
                                4. Humoral innate immunity and the acute phase response 1- Prof. Alberto Mantovani
 
- 
                                
                                5. Humoral innate immunity and the acute phase response 2- Prof. Alberto Mantovani
 
- 
                                
                                6. Arginase and nitric oxide- Dr. Peter Murray
 
- 
                                
                                7. Novel lipid mediators in resolution of inflammation- Prof. Charles Serhan
 
- 
                                
                                9. Iron metabolism and innate immunity- Prof. Tomas Ganz
 
- Pathogen-Host Interactions
- 
                                
                                10. Understanding and combating tuberculosis- Prof. David Russell
 
- Archived Lectures *These may not cover the latest advances in the field
- 
                                
                                12. Monocyte/macrophages in innate immunity- Prof. Emeritus Siamon Gordon
 
- 
                                
                                13. Innate immunity in C. elegans- Dr. Jonathan Ewbank
 
- 
                                
                                15. NLR genes: infection, inflammation and vaccines- Prof. Jenny Ting
 
- 
                                
                                16. Manipulation of innate immune response: lessons from shigella- Prof. Philippe Sansonetti
 
- 
                                
                                17. Innate immunity of the lung and adaptation to air breathing at birth- Prof. Jeffrey Whitsett
 
- 
                                
                                19. Innate-like lymphocytes 1- Prof. Adrian Hayday
 
- 
                                
                                20. Colony stimulating factor-1 regulation of macrophages in development and disease- Prof. E. Richard Stanley
 
- 
                                
                                21. Fc receptors: linking innate and acquired immunity- Prof. Ken G C Smith
 
- 
                                
                                22. Phagocytosis- Prof. Joel Swanson
 
- 
                                
                                23. Clearance of apoptotic cells and the control of inflammation- Prof. Sir John Savill
 
- 
                                
                                24. Signaling by innate immune receptors- Prof. Michael Karin
 
- 
                                
                                25. Phagocytosis in the fruit fly, Drosophila melanogaster- Dr. Lynda Stuart
 
- 
                                
                                26. Innate immune sensing and response- Prof. Bruce Beutler
 
- 
                                
                                27. Leukocyte recruitment in vivo- Prof. Paul Kubes
 
- 
                                
                                28. Cytokines regulating the innate response- Prof. Anne O’Garra
 
- 
                                
                                29. Cationic peptides in innate immunity- Dr. Dawn Bowdish
 
- 
                                
                                31. Innate recognition of viruses- Prof. Caetano Reis e Sousa
 
- 
                                
                                32. Innate-like lymphocytes 2- Prof. Adrian Hayday
 
- 
                                
                                33. The anti-microbial defense of Drosophila: a paradigm for innate immunity- Prof. Jules Hoffmann
 
- 
                                
                                34. Dendritic cells: linking innate to different forms of adaptive immunity- Prof. Ralph Steinman
 
- 
                                
                                35. NOD-like receptors in innate immunity and inflammatory disease- Prof. Gabriel Nunez
 
- 
                                
                                36. Innate immunity in children- Prof. David Speert
 
- 
                                
                                37. Innate immunity and malaria- Prof. Douglas Golenbock
 
- 
                                
                                38. From bench to bedside: evolution of anti-TNFalpha therapy in rheumatoid arthritis- Prof. Sir Ravinder Maini
 
- 
                                
                                39. The fate of monocytes in atherosclerosis- Prof. Gwendolyn Randolph
 
- 
                                
                                40. HIV-1 and immunopathogenesis: innate immunity- Prof. Luis Montaner
 
- 
                                
                                41. Paneth cells in innate immunity and inflammatory bowel disease- Prof. Satish Keshav
 
- 
                                
                                42. Macrophages, a cellular toolbox used by tumors to promote progression and metastasis- Prof. Jeffrey Pollard
 
- 
                                
                                43. Innate immunity in the brain in health and disease- Prof. V. Hugh Perry
 
- 
                                
                                44. Nuclear receptors at the crossroads of inflammation and atherosclerosis- Prof. Christopher Glass
 
- 
                                
                                45. Type I interferons in innate immunity to viral infections- Prof. Christine Biron
 
Printable Handouts
Navigable Slide Index
- Introduction
- Bacterial infection and inflammatory responses
- The first step of activation
- Pattern recognition receptors
- The TLR family
- Toll molecular structure
- MyD88
- The signalling pathways of Toll and TLR4
- Components of the signaling pathway
- NFkB as a central regulator
- NFkB transcription in mammals
- Ub modifications and their cellular functions
- MAP kinase signaling pathways
- LPS signaling pathways in human monocytes
- TRAF3 and the signaling complex
- Cytokines in TRAF3 deficient macrophages
- The entire INF response is TRAF3 dependent
- The TRAF3 signaling pathway
- Negative regulation of TLR signaling
- Pattern recognition receptors (2)
- TNFalpha induced apoptosis
- The TRAF family
- CD40 signaling and its functions in B cells
- The role of TRAFs in MAP kinase activation
- Roles of TRAF proteins in CD40 signaling
- Ubc13 E2 ubiquitin-conjugating enzyme
- MEKK1 activation
- CD40 complex assembly
- CD40 complex release to cytosol
- c-IAP1 and c-IAP2
- The role of c-IAP1 and c-IAP2 in complex release
- c-IAP2 target
- Polyubiquitination of TRAF2 and TRAF3
- c-IAP proteosome activity
- A model for TNF MAP kinase activation
- Why delay MAP kinase activity
- IKKalpha dependent alternative pathway
- Activation of IKKalpha by NIK
- TRAF3 recruits TRAF2 and c-IAPs to NIK
- cIAP1/2 regulate TRAF3 degradation
- The E3 ligase activity of c-IAP2
- A model for the alternative NFkB activation
- Pattern recognition receptors (3)
- The NLR Family
- Pathogen-associated receptors
- The inflammasomes and caspase-1
- Mechanism of action of NALP3
- Structure of the inflammasomes
- NFkB as a negative regulator of the inflammasome
- Regulation of IL-1beta production
- NFkB activation in macrophages and neutrophiles
- IL-1beta as an alternative immune response
- IL-1beta response to LT is dependent
- Summary
Topics Covered
- Understanding how receptors involved in the detection of infection (TLRs and NLRs) and inflammation (TNFRs) mediated their biological effects
- The activation of innate immune responses depends on recognition of infectious organisms (bacteria, fungi, viruses, etc.) by specialized pattern recognition receptors that include the large families of membrane-associated TLRs and cytosolic NLRs
- Signaling mechanisms used by TLRs and NLRs, as well as by TNFRs that respond to pro-inflammatory cytokines
- Their biological effects include the production of cytokines, chemokines, anti-microbial peptides and enzymes that generate inflammatory mediators and reactive oxygen
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Karin, M. (2009, May 31). Signaling by innate immune receptors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 30, 2025, from https://doi.org/10.69645/GCIX3503.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Michael Karin has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
 
       
    












































 
                    
                     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
     
        
      
    